Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 5 (2008), Issue 4 (April)

1. Bilateral malignant melanoma metastases to the internal auditory canal/cerebellopontine angle: surgical management and preservation of function.
   J Neurosurg, 108(4): 803-7. [Abstract] [Full-text]
2. Self-regulating hyperthermia induced using thermosensitive ferromagnetic material with a low Curie temperature.
   Cancer Sci, 99(4): 805-9. [Abstract] [Full-text]
3. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload.
   Ann Surg Oncol, 15(5): 1492-501. [Abstract] [Full-text]
4. Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma patients: superficial or superficial and deep lymph node dissection?
   Ann Surg Oncol, 15(5): 1485-91. [Abstract] [Full-text]
5. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
   Ann Surg Oncol, 15(5): 1476-84. [Abstract] [Full-text]
6. An effective vaccine strategy protective against antigenically distinct tumor variants.
   Cancer Res, 68(7): 2471-8. [Abstract] [Full-text]
7. Skewing the T-cell repertoire by combined DNA vaccination, host conditioning, and adoptive transfer.
   Cancer Res, 68(7): 2455-62. [Abstract] [Full-text]
8. B-1 lymphocytes increase metastatic behavior of melanoma cells through the extracellular signal-regulated kinase pathway.
   Cancer Sci, 99(5): 920-8. [Abstract] [Full-text]
9. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
   Am J Clin Oncol, 31(2): 173-81. [Abstract] [Full-text]
10. Collision of desmoplastic-neurotropic melanoma and squamous cell carcinoma on the lip.
    J Cutan Pathol, 35(5): 473-6. [Abstract] [Full-text]
11. Immunohistochemical characteristics of melanoma.
    J Cutan Pathol, 35(5): 433-44. [Abstract] [Full-text]
12. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Cancer, 112(8): 1795-804. [Abstract] [Full-text]
13. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
    Cancer, 112(8): 1787-94. [Abstract] [Full-text]
14. Emerging therapies for melanoma.
    Expert Rev Anticancer Ther, 8(4): 553-60. [Abstract] [Full-text]
15. Thick melanoma: the problem continues.
    J Eur Acad Dermatol Venereol, 22(5): 575-9. [Abstract] [Full-text]
16. Finger's amniotic membrane buffer technique: protecting the cornea during radiation plaque therapy.
    Arch Ophthalmol, 126(4): 531-4. [Abstract] [Full-text]
17. Identification of melanoma with a gas sensor array.
    Skin Res Technol, 14(2): 226-36. [Abstract] [Full-text]
18. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Cancer Res, 68(8): 2745-54. [Abstract] [Full-text]
19. Differential contribution of TAP and tapasin to HLA class I antigen expression.
    Immunology, 124(1): 112-20. [Abstract] [Full-text]
20. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
    Oncogene, 27(18): 2552-60. [Abstract] [Full-text]
21. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors.
    Science, 320(5874): 365-9. [Abstract] [Full-text]
22. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
    J Clin Oncol, 26(12): 2034-9. [Abstract] [Full-text]
23. Melanoma mimicking seborrheic keratosis: an error of perception precluding correct dermoscopic diagnosis.
    J Am Acad Dermatol, 58(5): 875-80. [Abstract] [Full-text]
24. Multiple skin metastases of malignant melanoma with unusual clinical and histopathologic features in an immunosuppressed patient.
    J Am Acad Dermatol, 58(5): 880-4. [Abstract] [Full-text]
25. Relationship and partner moderator variables increase self-efficacy of performing skin self-examination.
    J Am Acad Dermatol, 58(5): 755-62. [Abstract] [Full-text]
26. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    J Am Acad Dermatol, 58(5): 750-4. [Abstract] [Full-text]
27. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    J Am Acad Dermatol, 58(5): 741-9. [Abstract] [Full-text]
28. OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas.
    Am J Surg, 195(5): 621-5; discussion 625. [Abstract] [Full-text]
29. Detection of second primary cutaneous melanomas.
    Eur J Surg Oncol, 34(5): 587-92. [Abstract] [Full-text]
30. An inquiry into the nature of the pigmented lesion above Franklin Delano Roosevelt's left eyebrow.
    Arch Dermatol, 144(4): 529-32. [Abstract] [Full-text]
31. Suppression of melanoma-associated neoangiogenesis by bevacizumab.
    Arch Dermatol, 144(4): 525-7. [Abstract] [Full-text]
32. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
    Arch Dermatol, 144(4): 515-21. [Abstract] [Full-text]
33. Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter study.
    Arch Dermatol, 144(4): 509-13. [Abstract] [Full-text]
34. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma.
    Arch Dermatol, 144(4): 502-6. [Abstract] [Full-text]
35. Multiple levels of influence in the adoption of sun protection policies in elementary schools in Massachusetts.
    Arch Dermatol, 144(4): 491-6. [Abstract] [Full-text]
36. Indoor tanning knowledge, attitudes, and behavior among young adults from 1988-2007.
    Arch Dermatol, 144(4): 484-8. [Abstract] [Full-text]
37. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas.
    Arch Dermatol, 144(4): 476-82. [Abstract] [Full-text]
38. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma.
    Arch Dermatol, 144(4): 469-74. [Abstract] [Full-text]
39. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Arch Dermatol, 144(4): 462-7. [Abstract] [Full-text]
40. Mohs micrographic surgery is accurate 95.1% of the time for melanoma in situ: a prospective study of 167 cases.
    Dermatol Surg, 34(5): 660-4. [Abstract] [Full-text]
41. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Ann Surg, 247(4): 687-93. [Abstract] [Full-text]
42. Autofluorescence of choroidal melanoma in 51 cases.
    Br J Ophthalmol, 92(5): 617-22. [Abstract] [Full-text]
43. Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.
    Cancer, 112(9): 2030-7. [Abstract] [Full-text]
44. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production.
    J Cell Physiol, 216(1): 180-8. [Abstract] [Full-text]
45. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
    J Clin Oncol, 26(13): 2178-85. [Abstract] [Full-text]
46. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
    J Clin Oncol, 26(13): 2139-46. [Abstract] [Full-text]
47. Never perform laser treatment of skin tumors with clinical "EFG" criteria.
    J Dtsch Dermatol Ges, 6(5): 386-8. [Abstract] [Full-text]
48. Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas.
    Int J Cancer, 123(1): 227-31. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.